SUCCURA DAVIS: Open Payments
NPI 1467962746 · MC FARLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 8 payments from 7 companies in 2025. Trend: 2023 $263 · 2024 $763 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $242 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $110 |
| Lilly USA, LLC | 1 | $97 |
| Exact Sciences Corporation | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: FANAPT, BREZTRI, AREXVY, ZEPBOUND, Cologuard Collection Kit, COBENFY, ACCRUFER.
Industry payments across CA — which companies pay providers there.
